AI Verdict
RENXF has stronger fundamentals based on our AI analysis.
REPL vs RENXF Fundamental Comparison
| Metric | REPL | RENXF |
|---|---|---|
| Revenue | $0.0 | $522,000.0 |
| Net Income | $-240.7M | $-4.7M |
| Net Margin | N/A | -905.7% |
| ROE | -114.3% | N/A |
| ROA | -72.2% | -98.6% |
| Current Ratio | 5.60x | 0.24x |
| Debt/Equity | 0.23x | N/A |
| EPS | $-2.62 | $-0.04 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
REPL vs RENXF: Frequently Asked Questions
Is REPL or RENXF a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RENXF has stronger fundamentals. REPL is rated STRONG SELL (75% confidence) while RENXF is rated STRONG SELL (95% confidence). This is not investment advice.
How does REPL compare to RENXF fundamentally?
Replimune Group, Inc. has ROE of -114.3% vs Renalytix plc's N/A. Net margins are N/A vs -905.7% respectively.
Which stock pays higher dividends, REPL or RENXF?
REPL has a dividend yield of N/A or no dividend while RENXF has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in REPL or RENXF for long term?
For long-term investing, consider that REPL has STRONG SELL rating with 75% confidence, while RENXF has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about REPL vs RENXF?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For REPL vs RENXF, the AI consensus favors RENXF based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.